GALECTIN THERAPEUTICS INC (GALT)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Research & development$14.3M$36.6M$32.1M$31.7M$23.8M$18.0M$7.5M$6.5M$11.7M$15.3M$13.1M$8.4M$5.7M$4.5M$3.6M$1.1M
Operating expenses$20.1M$42.4M$38.1M$38.4M$30.2M$23.4M$13.4M$13.6M$16.2M$21.5M$20.1M$15.4M$12.1M$9.9M$10.4M$4.9M
Operating income−$20.1M−$42.4M−$38.1M−$38.4M−$30.2M−$23.4M−$13.4M−$13.6M−$16.2M−$21.5M−$20.1M−$15.4M−$12.1M−$9.9M−$10.4M−$4.9M
EBITDAderived−$42.4M−$38.1M−$38.4M−$30.2M−$23.4M−$13.4M−$13.6M−$16.2M−$21.5M−$20.1M−$15.4M−$12.1M−$9.9M−$10.4M−$4.9M
Net income−$30.8M−$47.0M−$41.1M−$38.8M−$30.5M−$23.5M−$13.3M−$13.9M−$16.2M−$21.4M−$20.0M−$15.8M−$12.1M−$9.7M−$10.9M−$5.6M
Basic EPSper diluted share-$0.48-$0.76-$0.74-$0.65-$0.52-$0.41-$0.39-$0.38-$0.49-$0.76-$0.88-$0.78-$1.30-$0.72-$1.06-$0.93
Diluted EPSper diluted share-$0.48-$0.76-$0.74-$0.65-$0.52-$0.41-$0.39-$0.38-$0.49-$0.76-$0.88-$0.78-$1.30-$0.72-$1.06-$0.93

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys21$158.6K disclosed value
Sells (SEC code S)75$7.23M disclosed value
96 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 29, 2026Form 4 · 10b5-1Shlevin Harold H.DirectorSellCommon Stock22.3K$5.04$112.2K6.5K
Jun 29, 2026Form 4 · 10b5-1Jamil KhurramChief Medical OfficerSellCommon Stock47.5K$5.04$239.2K0
Jun 26, 2026Form 4 · 10b5-1Shlevin Harold H.DirectorSellCommon Stock7.7K$5.00$38.7K6.5K
Jun 26, 2026Form 4 · 10b5-1Jamil KhurramChief Medical OfficerSellCommon Stock2.5K$5.00$12.7K0
Jun 26, 2026Form 4 · 10b5-1Jamil KhurramChief Medical OfficerSellCommon Stock2.0K$5.00$10.2K0